Literature DB >> 29108965

IL-1/inhibitory κB kinase ε-induced glycolysis augment epithelial effector function and promote allergic airways disease.

Xi Qian1, Reem Aboushousha1, Cheryl van de Wetering2, Shi B Chia1, Eyal Amiel3, Robert W Schneider1, Jos L J van der Velden1, Karolyn G Lahue1, Daisy A Hoagland1, Dylan T Casey1, Nirav Daphtary4, Jennifer L Ather4, Matthew J Randall4, Minara Aliyeva4, Kendall E Black4, David G Chapman5, Lennart K A Lundblad4, David H McMillan1, Anne E Dixon4, Vikas Anathy1, Charles G Irvin4, Matthew E Poynter4, Emiel F M Wouters2, Pamela M Vacek6, Monique Henket7, Florence Schleich7, Renaud Louis7, Albert van der Vliet1, Yvonne M W Janssen-Heininger8.   

Abstract

BACKGROUND: Emerging studies suggest that enhanced glycolysis accompanies inflammatory responses. Virtually nothing is known about the relevance of glycolysis in patients with allergic asthma.
OBJECTIVES: We sought to determine whether glycolysis is altered in patients with allergic asthma and to address its importance in the pathogenesis of allergic asthma.
METHODS: We examined alterations in glycolysis in sputum samples from asthmatic patients and primary human nasal cells and used murine models of allergic asthma, as well as primary mouse tracheal epithelial cells, to evaluate the relevance of glycolysis.
RESULTS: In a murine model of allergic asthma, glycolysis was induced in the lungs in an IL-1-dependent manner. Furthermore, administration of IL-1β into the airways stimulated lactate production and expression of glycolytic enzymes, with notable expression of lactate dehydrogenase A occurring in the airway epithelium. Indeed, exposure of mouse tracheal epithelial cells to IL-1β or IL-1α resulted in increased glycolytic flux, glucose use, expression of glycolysis genes, and lactate production. Enhanced glycolysis was required for IL-1β- or IL-1α-mediated proinflammatory responses and the stimulatory effects of IL-1β on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal epithelial cells. Inhibitor of κB kinase ε was downstream of HDM or IL-1β and required for HDM-induced glycolysis and pathogenesis of allergic airways disease. Small interfering RNA ablation of lactate dehydrogenase A attenuated HDM-induced increases in lactate levels and attenuated HDM-induced disease. Primary nasal epithelial cells from asthmatic patients intrinsically produced more lactate compared with cells from healthy subjects. Lactate content was significantly higher in sputum supernatants from asthmatic patients, notably those with greater than 61% neutrophils. A positive correlation was observed between sputum lactate and IL-1β levels, and lactate content correlated negatively with lung function.
CONCLUSIONS: Collectively, these findings demonstrate that IL-1β/inhibitory κB kinase ε signaling plays an important role in HDM-induced glycolysis and pathogenesis of allergic airways disease.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; IL-1; glycolysis; house dust mite; inhibitor of κB kinase ε; lactate; lactate dehydrogenase A

Mesh:

Substances:

Year:  2017        PMID: 29108965      PMCID: PMC6278819          DOI: 10.1016/j.jaci.2017.08.043

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  52 in total

1.  Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma.

Authors:  G J Rodrigo; C Rodrigo
Journal:  Emerg Med J       Date:  2005-06       Impact factor: 2.740

Review 2.  Canakinumab for the treatment of chronic obstructive pulmonary disease.

Authors:  Paola Rogliani; Luigino Calzetta; Josuel Ora; Maria Gabriella Matera
Journal:  Pulm Pharmacol Ther       Date:  2015-02-04       Impact factor: 3.410

Review 3.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

4.  Mechanism of TH2/TH17-predominant and neutrophilic TH2/TH17-low subtypes of asthma.

Authors:  Weimin Liu; Sucai Liu; Mukesh Verma; Iram Zafar; James T Good; Donald Rollins; Stephen Groshong; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2016-10-01       Impact factor: 10.793

5.  Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells.

Authors:  Jane E Tully; James D Nolin; Amy S Guala; Sidra M Hoffman; Elle C Roberson; Karolyn G Lahue; Jos van der Velden; Vikas Anathy; Timothy S Blackwell; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-31       Impact factor: 6.914

6.  Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function.

Authors:  Jonathan Jantsch; Dipshikha Chakravortty; Nadine Turza; Alexander T Prechtel; Björn Buchholz; Roman G Gerlach; Melanie Volke; Joachim Gläsner; Christina Warnecke; Michael S Wiesener; Kai-Uwe Eckardt; Alexander Steinkasserer; Michael Hensel; Carsten Willam
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 7.  The relevance of tumour pH to the treatment of malignant disease.

Authors:  J L Wike-Hooley; J Haveman; H S Reinhold
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

8.  Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness.

Authors:  Cristen Pantano; Jennifer L Ather; John F Alcorn; Matthew E Poynter; Amy L Brown; Amy S Guala; Stacie L Beuschel; Gilman B Allen; Laurie A Whittaker; Mieke Bevelander; Charles G Irvin; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

9.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.

Authors:  Oscar R Colegio; Ngoc-Quynh Chu; Alison L Szabo; Thach Chu; Anne Marie Rhebergen; Vikram Jairam; Nika Cyrus; Carolyn E Brokowski; Stephanie C Eisenbarth; Gillian M Phillips; Gary W Cline; Andrew J Phillips; Ruslan Medzhitov
Journal:  Nature       Date:  2014-07-13       Impact factor: 69.504

10.  Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.

Authors:  Caroline Dive; Christopher J Morrow; Radosław Polański; Cassandra L Hodgkinson; Alberto Fusi; Daisuke Nonaka; Lynsey Priest; Paul Kelly; Francesca Trapani; Paul W Bishop; Anne White; Susan E Critchlow; Paul D Smith; Fiona Blackhall
Journal:  Clin Cancer Res       Date:  2013-11-25       Impact factor: 12.531

View more
  15 in total

Review 1.  Role and mechanisms of autophagy in lung metabolism and repair.

Authors:  Xue Li; Fuxiaonan Zhao; An Wang; Peiyong Cheng; Huaiyong Chen
Journal:  Cell Mol Life Sci       Date:  2021-04-17       Impact factor: 9.261

2.  Pyruvate Kinase M2 Promotes Expression of Proinflammatory Mediators in House Dust Mite-Induced Allergic Airways Disease.

Authors:  Cheryl van de Wetering; Reem Aboushousha; Allison M Manuel; Shi B Chia; Cuixia Erickson; Maximilian B MacPherson; Jos L van der Velden; Vikas Anathy; Anne E Dixon; Charles G Irvin; Matthew E Poynter; Albert van der Vliet; Emiel F M Wouters; Niki L Reynaert; Yvonne M W Janssen-Heininger
Journal:  J Immunol       Date:  2020-01-10       Impact factor: 5.422

3.  Therapeutic ketosis decreases methacholine hyperresponsiveness in mouse models of inherent obese asthma.

Authors:  Madeleine M Mank; Leah F Reed; Camille J Walton; Madison L T Barup; Jennifer L Ather; Matthew E Poynter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-22       Impact factor: 5.464

4.  Bioenergetic Differences in the Airway Epithelium of Lean Versus Obese Asthmatics Are Driven by Nitric Oxide and Reflected in Circulating Platelets.

Authors:  Daniel Winnica; Catherine Corey; Steven Mullett; Michael Reynolds; Gabrielle Hill; Stacy Wendell; Loretta Que; Fernando Holguin; Sruti Shiva
Journal:  Antioxid Redox Signal       Date:  2019-03-06       Impact factor: 8.401

5.  Pyruvate kinase M2 in lung APCs regulates Alternaria-induced airway inflammation.

Authors:  Anil Kumar Jaiswal; Sangeet Makhija; Natalie Stahr; Maninder Sandey; Amol Suryawanshi; Amarjit Mishra
Journal:  Immunobiology       Date:  2020-05-30       Impact factor: 3.144

Review 6.  Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases.

Authors:  Charalambos Michaeloudes; Pankaj K Bhavsar; Sharon Mumby; Bingling Xu; Christopher Kim Ming Hui; Kian Fan Chung; Ian M Adcock
Journal:  J Innate Immun       Date:  2019-11-29       Impact factor: 7.349

7.  Therapeutic efficacy of IL-17A neutralization with corticosteroid treatment in a model of antigen-driven mixed-granulocytic asthma.

Authors:  Katherine E Menson; Madeleine M Mank; Leah F Reed; Camille J Walton; Katherine E Van Der Vliet; Jennifer L Ather; David G Chapman; Bradford J Smith; Mercedes Rincon; Matthew E Poynter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-12       Impact factor: 5.464

8.  Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation.

Authors:  Diana C Contreras Healey; Jacqueline Y Cephus; Sierra M Barone; Nowrin U Chowdhury; Debolanle O Dahunsi; Matthew Z Madden; Xiang Ye; Xuemei Yu; Kellen Olszewski; Kirsten Young; Valerie A Gerriets; Peter J Siska; Ryszard Dworski; Jonathan Hemler; Jason W Locasale; Masha V Poyurovsky; R Stokes Peebles; Jonathan M Irish; Dawn C Newcomb; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2021-02-08       Impact factor: 5.422

Review 9.  Metabolomics in asthma: A platform for discovery.

Authors:  Shengjie Xu; Reynold A Panettieri; Joseph Jude
Journal:  Mol Aspects Med       Date:  2021-07-17

10.  Glutathionylation chemistry promotes interleukin-1 beta-mediated glycolytic reprogramming and pro-inflammatory signaling in lung epithelial cells.

Authors:  Reem Aboushousha; Evan Elko; Shi B Chia; Allison M Manuel; Cheryl van de Wetering; Jos van der Velden; Maximilian MacPherson; Cuixia Erickson; Julie A Reisz; Angelo D'Alessandro; Emiel F M Wouters; Niki L Reynaert; Ying-Wai Lam; Vikas Anathy; Albert van der Vliet; David J Seward; Yvonne M W Janssen-Heininger
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.